Our top pick for
US stocks

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PainChek is a health information services business based in Australia. PainChek shares (PCK) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. PainChek has a trailing 12-month revenue of around $448,632. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
Best overall broker
Our top pick for
Best low-cost broker
52-week range | $0.029 - $0.068 |
---|---|
50-day moving average | $0.0376 |
200-day moving average | $0.0459 |
Target price | $0.1 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.006 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.032
1 month (2022-05-26) | -17.95% |
---|---|
3 months (2022-03-25) | -17.95% |
6 months (2021-12-24) | -40.74% |
1 year (2021-06-25) | -46.67% |
---|---|
2 years (2020-06-26) | -73.33% |
3 years (2019-06-26) | -82.22% |
Revenue TTM | $448,632 |
---|---|
Gross profit TTM | $-405,123 |
Return on assets TTM | -38.34% |
Return on equity TTM | -67.54% |
Profit margin | 0% |
Book value | 0.006 |
Market capitalisation | $37.4 million |
TTM: trailing 12 months
We're not expecting PainChek to pay a dividend over the next 12 months.
PainChek 's shares were split on a 4:7 basis on 2 September 2016. So if you had owned 7 shares the day before the split, the next day you would own 4 shares. This wouldn't directly have changed the overall worth of your PainChek shares – just the quantity. However, indirectly, the new 75% higher share price could have impacted the market appetite for PainChek shares which in turn could have impacted PainChek 's share price.
Over the last 12 months, PainChek 's shares have ranged in value from as little as $0.029 up to $0.068. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while PainChek 's is 0.1976. This would suggest that PainChek 's shares are less volatile than average (for this exchange).
PainChek Limited develops and commercializes mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets to capture video that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.
Steps to owning and managing Kincora Copper shares.
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
Steps to owning and managing Arcadia Minerals shares.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.